Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-12 · accession 0001411690-23-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2023-05-12 | BNGO | Holmlin R. Erik | Pres, CEO, Dir | F - Tax | $0.66 | -50.1K | 791.5K | -6% | -$33.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-12 | F | D | 50,141 | $0.66 | 791,474 | D | — | — |